Position in GILD
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$1,955,221
+$387,095 QoQ
Shares Held
14,029
+9.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.39%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
16 quarters on record
Voting authority
Sole 85%
Shared 0%
None 15%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Derivatives in GILD
reported options exposure · as of Dec 31, 2025CallValue
$36,822
CallShares
300
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026DGS Capital Management, LLC holds $21,433,187 across 14 Drug Manufacturers - General names. GILD ranks #5 (9.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
13,631 | $3,331,961 | |
| 2 | NVS |
Novartis AG
|
21,135 | $3,228,371 | |
| 3 | LLY |
ELI LILLY & Co
|
3,475 | $3,196,200 | |
| 4 | GSK |
GSK plc
|
42,695 | $2,356,337 | |
| 5 | GILD |
Gilead Sciences, Inc.
This page
|
14,029 | $1,955,221 | |
| 6 | MRK |
Merck & Co., Inc.
|
14,018 | $1,686,225 | |
| 7 | ABBV |
AbbVie Inc.
|
6,748 | $1,467,622 | |
| 8 | NVO |
Novo Nordisk A S
|
31,948 | $1,174,089 |
All Filings in GILD
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,955,221 | 14,029 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $36,822 | 300 | Call | Sole | 2026-02-24 | |
| 2025-12-31 | $1,568,126 | 12,776 | Shares | Sole | 2026-02-24 | |
| 2025-09-30 | $1,251,747 | 11,277 | Shares | Sole | 2026-02-24 | |
| 2025-06-30 | $1,067,012 | 9,624 | Shares | Sole | 2026-02-24 | |
| 2025-03-31 | $700,648 | 6,253 | Shares | Sole | 2026-02-24 | |
| 2024-12-31 | $302,234 | 3,272 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $299,644 | 3,574 | Shares | Sole | 2024-12-10 | |
| 2024-06-30 | $347,578 | 5,066 | Shares | Sole | 2024-12-10 | |
| 2024-03-31 | $645,259 | 8,809 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $630,905 | 7,788 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $574,490 | 7,666 | Shares | Sole | 2024-01-30 | |
| 2023-06-30 | $518,835 | 6,732 | Shares | Sole | 2024-01-30 | |
| 2023-03-31 | $545,112 | 6,570 | Shares | Sole | 2023-06-16 | |
| 2022-12-31 | $552,788 | 6,439 | Shares | Sole | 2023-02-21 | |
| 2022-09-30 | $406,105 | 6,583 | Shares | Sole | 2023-02-21 | |
| 2022-06-30 | $306,824 | 4,964 | Shares | Sole | 2022-07-28 | |
| No filing history on record for this holder in this stock. | ||||||